Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger

被引:3
作者
Makabe, Takeshi [1 ]
Yamagami, Wataru [1 ]
Hirasawa, Akira [2 ]
Miyabe, Izumi [3 ]
Wakatsuki, Tomokazu [3 ]
Kikuchi, Mari [3 ]
Takahashi, Akemi [3 ]
Noda, Junko [3 ]
Yamamoto, Go [3 ]
Aoki, Daisuke [1 ]
Akagi, Kiwamu [3 ]
机构
[1] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 1608582, Japan
[2] Okayama Univ, Dept Clin Genom Med, Okayama 7008530, Japan
[3] Saitama Canc Ctr, Div Mol Diag & Canc Prevent, Saitama 3620806, Japan
关键词
Lynch syndrome; Endometrial cancer; Young; Japanese; COLORECTAL-CANCER; MUTATION; WOMEN; MUTYH; CARCINOMA; RISKS; IMMUNOHISTOCHEMISTRY; IMPLEMENTATION; IDENTIFICATION; STRATEGIES;
D O I
10.1007/s10147-021-01953-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[Objective] Lynch syndrome (LS) is an autosomal dominant inherited disorder caused by a germline pathogenic variant in DNA mismatch repair (MMR) genes. Endometrial cancer frequently precedes another LS-associated tumor. This study aimed to clarify the incidence and features of LS in young Japanese endometrial cancer patients. [Methods] Sixty-five patients aged 40 years or younger, who were diagnosed with endometrial cancer, were enrolled in this study. Targeted sequencing of a hereditary colorectal cancer-related gene panel including the MMR genes MLH1, MSH2, MSH6, and PMS2 was conducted on DNA samples extracted from blood cells. [Results] Overall, 6 missense variants (2 in MSH2, 2 in MSH6, and 2 in PMS2), 1 inframe deletion variant in MSH2, 1 splice variant in MSH2, and 1 two-base substitution in the 3' untranslated region in MLH1 were detected in 9 (13.8%) patients. Among these, the splice variant c.1276G > T (p.Ile411_Gly426del16) in MSH2 was annotated as pathogenic, while other variants were of uncertain significance. The patient with the pathogenic variant had a family history of endometrial and colorectal cancer and was diagnosed with endometrial cancer at age 35. [Conclusion] The incidence of LS among Japanese endometrial cancer patients of reproductive age (<= 40 years) in this study was at least 1.5%; however, 12.3% of patients had variants of uncertain significance in MMR genes.
引用
收藏
页码:1767 / 1774
页数:8
相关论文
共 44 条
  • [1] Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO
  • [2] 2-L
  • [3] Universal Screening of Both Endometrial and Colon Cancers Increases the Detection of Lynch Syndrome
    Adar, Tomer
    Rodgers, Linda H.
    Shannon, Kristen M.
    Yoshida, Makoto
    Ma, Tianle
    Mattia, Anthony
    Lauwers, Gregory Y.
    Iafrate, Anthony J.
    Hartford, Nicole M.
    Oliva, Esther
    Chung, Daniel C.
    [J]. CANCER, 2018, 124 (15) : 3145 - 3153
  • [4] Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76
  • [5] A method and server for predicting damaging missense mutations
    Adzhubei, Ivan A.
    Schmidt, Steffen
    Peshkin, Leonid
    Ramensky, Vasily E.
    Gerasimova, Anna
    Bork, Peer
    Kondrashov, Alexey S.
    Sunyaev, Shamil R.
    [J]. NATURE METHODS, 2010, 7 (04) : 248 - 249
  • [6] [Anonymous], 2003, WHO CLASSIFICATION T
  • [7] Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
    Baglietto, Laura
    Lindor, Noralane M.
    Dowty, James G.
    White, Darren M.
    Wagner, Anja
    Garcia, Encarna B. Gomez
    Vriends, Annette H. J. T.
    Cartwright, Nicola R.
    Barnetson, Rebecca A.
    Farrington, Susan M.
    Tenesa, Albert
    Hampel, Heather
    Buchanan, Daniel
    Arnold, Sven
    Young, Joanne
    Walsh, Michael D.
    Jass, Jeremy
    Macrae, Finlay
    Antill, Yoland
    Winship, Ingrid M.
    Giles, Graham G.
    Goldblatt, Jack
    Parry, Susan
    Suthers, Graeme
    Leggett, Barbara
    Butz, Malinda
    Aronson, Melyssa
    Poynter, Jenny N.
    Baron, John A.
    Le Marchand, Loic
    Haile, Robert
    Gallinger, Steve
    Hopper, John L.
    Potter, John
    de la Chapelle, Albert
    Vasen, Hans F.
    Dunlop, Malcolm G.
    Thibodeau, Stephen N.
    Jenkins, Mark A.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03): : 193 - 201
  • [8] Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis
    Berends, MJW
    Wu, Y
    Sijmons, RH
    van der Sluis, T
    Ek, WB
    Ligtenberg, MJL
    Arts, NJW
    ten Hoor, KA
    Kleibeuker, JH
    de Vries, EGE
    Mourits, MJE
    Hollema, H
    Buys, CHCM
    Hofstra, RMW
    van der Zee, AGJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4364 - 4370
  • [9] Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
    Bonadona, Valerie
    Bonaiti, Bernard
    Olschwang, Sylviane
    Grandjouan, Sophie
    Huiart, Laetitia
    Longy, Michel
    Guimbaud, Rosine
    Buecher, Bruno
    Bignon, Yves-Jean
    Caron, Olivier
    Colas, Chrystelle
    Nogues, Catherine
    Lejeune-Dumoulin, Sophie
    Olivier-Faivre, Laurence
    Polycarpe-Osaer, Florence
    Nguyen, Tan Dat
    Desseigne, Francoise
    Saurin, Jean-Christophe
    Berthet, Pascaline
    Leroux, Dominique
    Duffour, Jacqueline
    Manouvrier, Sylvie
    Frebourg, Thierry
    Sobol, Hagay
    Lasset, Christine
    Bonaiti-Pellie, Catherine
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2304 - 2310
  • [10] Tumor Mismatch Repair Immunohistochemistry and DNA MLH1 Methylation Testing of Patients With Endometrial Cancer Diagnosed at Age Younger Than 60 Years Optimizes Triage for Population-Level Germline Mismatch Repair Gene Mutation Testing
    Buchanan, Daniel D.
    Tan, Yen Y.
    Walsh, Michael D.
    Clendenning, Mark
    Metcalf, Alexander M.
    Ferguson, Kaltin
    Arnold, Sven T.
    Thompson, Bryony A.
    Lose, Felicity A.
    Parsons, Michael T.
    Walters, Rhiannon J.
    Pearson, Sally-Ann
    Cummings, Margaret
    Oehler, Martin K.
    Blomfield, Penelope B.
    Quinn, Michael A.
    Kirk, Judy A.
    Stewart, Colin J.
    Obermair, Andreas
    Young, Joanne P.
    Webb, Penelope M.
    Spurdle, Amanda B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (02) : 90 - +